The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells
Open accessAbstract
T lymphocytes expressing the T cell receptor (TCR)-γδ recognize unknown antigens on tumor cells. Here we identify metabolites of the mevalonate pathway as the tumor ligands that activate TCR-γδ cells. In tumor cells, blockade of hydroxy-methylglutaryl-CoA reductase (HMGR), the rate limiting enzyme of the mevalonate pathway, prevents both accumulation of mevalonate metabolites and recognition by TCR-γδ cells. When metabolite accumulation is induced by overexpressing HMGR or by treatment with nitrogen-containing bisphosphonate drugs, tumor cells derived from many tissues acquire the capacity to stimulate the same TCR-γδ population. Accumulation of mevalonate metabolites in tumor cells is a powerful danger signal that activates the immune response and may represent a novel target of tumor immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
Natural and synthetic non-peptide antigens recognized by human γδ T cells
Tanaka, Y., Morita, C. T., Tanaka, Y., Nieves, E., Brenner, M. B., & Bloom, B. R. (1995) · Nature · doi:10.1038/375155a0 · Cited by 1,013
Dunford, J. E., Thompson, K., Coxon, F. P., Luckman, S. P., Hahn, F. M., Poulter, C. D., Ebetino, F. H., & Rogers, M. J. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38786-5 · Cited by 900
Stimulation of Human γδ T Cells by Nonpeptidic Mycobacterial Ligands
Constant, P., Davodeau, F., Peyrat, M.-A., Poquet, Y., Puzo, G., Bonneville, M., & Fournié, J.-J. (1994) · Science · doi:10.1126/science.8146660 · Cited by 711
Kunzmann, V., Bauer, E., Feurle, J., Tony, F. W., & Wilhelm, M. (2000) · Blood · doi:10.1182/blood.v96.2.384 · Cited by 669
Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells
Morita, C. T., Beckman, E. M., Bukowski, J. F., Tanaka, Y., Band, H., Bloom, B. R., Golan, D. E., & Brenner, M. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90178-7 · Cited by 470
Sterols and Isoprenoids: Signaling Molecules Derived from the Cholesterol Biosynthetic Pathway
Edwards, P. A., & Ericsson, J. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.157 · Cited by 458
Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate Synthase
Bergstrom, J. D., Bostedor, R. G., Masarachia, P. J., Reszka, A. A., & Rodan, G. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1502 · Cited by 402
Recognition by Human V γ 9/V δ 2 T Cells of a GroEL Homolog on Daudi Burkitt's Lymphoma Cells
Fisch, P., Malkovsky, M., Kovats, S., Sturm, E., Braakman, E., Klein, B. S., Voss, S. D., Morrissey, L. W., DeMars, R., Welch, W. J., et al. (1990) · Science · doi:10.1126/science.1978758 · Cited by 358
Nakanishi, M., Goldstein, J. L., & Brown, M. S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68397-8 · Cited by 332
De Libero, G., Casorati, G., Giachino, C., Carbonara, C., Migone, N., Matzinger, P., & Lanzavecchia, A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.6.1311 · Cited by 202
Self-citationBiology of the Human γ T‐Cell Receptor
Porcelli, S., Brenner, M. B., & Band, H. (1991) · Immunological Reviews · doi:10.1111/j.1600-065x.1991.tb00591.x · Cited by 185
Vγ2Vδ2 T-cell receptor–mediated recognition of aminobisphosphonates
Das, H., Wang, L., Kamath, A., & Bukowski, J. F. (2001) · Blood · doi:10.1182/blood.v98.5.1616 · Cited by 178
Correll, C. C., Ng, L., & Edwards, P. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32450-x · Cited by 172
Ness, G. C., & Chambers, C. M. (2000) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22359.x · Cited by 169
Antigen recognition by human γδ T cells: pattern recognition by the adaptive immune system
Morita, C. T., Mariuzza, R. A., & Brenner, M. B. (2000) · Springer Seminars in Immunopathology · doi:10.1007/s002810000042 · Cited by 165
Bürk, M. R., Mori, L., & de Libero, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250737 · Cited by 160
Self-citationTargeting of Tumor Cells for Human γδ T Cells by Nonpeptide Antigens
Kato, Y., Tanaka, Y., Miyagawa, F., Yamashita, S., & Minato, N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5092 · Cited by 146
3-Formyl-1-butyl Pyrophosphate A Novel Mycobacterial Metabolite-activating Human γδ T Cells
Belmant, C., Espinosa, É., Poupot, R., Peyrat, M., Guiraud, M., Poquet, Y., Bonneville, M., & Fournié, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32079 · Cited by 122
Dimitroulakos, J., & Yeger, H. (1996) · Nature Medicine · doi:10.1038/nm0396-326 · Cited by 104
Harwood, H., Alvarez, I. M., Noyes, W. D., et al. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41954-6 · Cited by 72
Escherichia coli Produces Phosphoantigens Activating Human γδ T Cells
Feurle, J., Espinosa, É., Eckstein, S., Pont, F., Kunzmann, V., Fournié, J., Herderich, M. J., & Wilhelm, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106443200 · Cited by 57
Antilymphoma activity of human gamma delta T-cells in mice with severe combined immune deficiency.
Malkovska, V., Cigel, F., Armstrong, N., Storer, B. E., & Hong, R. (1992) · PubMed · Cited by 49
Selin, L. K., STEWART, S., Shen, C., MAO, H. Q., & Wilkins, J. A. (1992) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1992.tb02946.x · Cited by 48
Honda, M., Tint, G. S., Honda, A., Nguyen, L. B., Chen, T. C., & Shefer, S. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33302-2 · Cited by 40
Activation of the cholesterol pathway and Ras maturation in response to stress
Shack, S., Gorospe, M., Fawcett, T. W., Hudgins, W. R., & Holbrook, N. J. (1999) · Oncogene · doi:10.1038/sj.onc.1203002 · Cited by 39
Cited by
Six-of-the-best: unique contributions of γδ T cells to immunology
Vantourout, P., & Hayday, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3384 · Cited by 1,232
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
γδ T Cells: First Line of Defense and Beyond
Chien, Y.-H., Meyer, C., & Bonneville, M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120216 · Cited by 636
Mevalonate pathway: A review of clinical and therapeutical implications
Buhaescu, I., & Izzedine, H. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.03.016 · Cited by 620
Innate Immune Recognition of Cancer
Woo, S.-R., Corrales, L., & Gajewski, T. F. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112043 · Cited by 571
Metadata
- Authors
- Gober, H.-J., Kistowska, M., Angman, L., Jenö, P., Mori, L., & De Libero, G.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-01-13
- Volume
- 197
- Issue
- 2
- Pages
- 163-168
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2170263258
- Cited by
- 847
- References
- 27
- FWCI
- 8.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.